Skip to main content
Premium Trial:

Request an Annual Quote

Denichiro Otsuga, Kevin Kephart, Mark Coticchia, Eric Fingerhut, James Reddoch, Steven Hanle, Jennifer Trusso

Premium
South Dakota State University has named Denichiro Otsuga as the university’s first director of technology transfer, Kevin Kephart, SDSU’s vice president for research, said last week.
 
Otsuga joins SDSU from Ceres, a California-based energy crop-development company, where he was manager of technology licensing and acquisition. Prior to that, he worked in the technology transfer office at the University of Utah. He also received a PhD in developmental plant molecular genetics from the University of Utah.
 

 
Mark Coticchia, vice president for research and technology management at Case Western Reserve University, has been named senior economic development adviser to Ohio Board of Regents Chancellor Eric Fingerhut.
 
Coticchia is an “executive on loan” from Case Western, and will be responsible for assisting Fingerhut in launching the Board of Regents’ new Division of Economic Advancement.
 
Prior to joining CWRU, Coticchia was senior director of Redleaf Group, an early-stage venture capital firm. From 1997 to 2000, Coticchia was director of technology transfer at Carnegie Mellon University. He received his MS and BS degrees in industrial engineering and management, and civil engineering from the University of Pittsburgh.
 

 
Royalty Pharma said this week that James Reddoch has joined the company as executive vice president, head of research.
 
Reddoch has spent the last 12 years as an equity analyst, most recently as managing director of biotechnology and head of the healthcare group at FBR Capital Markets. He previously worked at Banc of America Securities and CIBC World Markets, now called Oppenheimer & Co.
Reddoch holds a BA from Furman University, a PhD in biochemistry and molecular genetics from the University of Alabama at Birmingham, and was a postdoc at Yale University School of Medicine.
 

 
Law firm Sheppard, Mullin, Richter & Hampton said last week that Steven Hanle and Jennifer Trusso have joined the firm’s Orange County, Calif., office in the intellectual property group.
 
Hanle and Trusso were previously partners at Stradling Yocca Carlson & Rauth in Orange County.
 
Hanle and Trusso specialize in patent litigation in a wide range of technologies, including pharmaceuticals, medical devices, computer software and hardware, manufacturing technologies, and optics. They were recently part of a team that prevailed at trial and on appeal for Amphastar Pharmaceuticals in a major patent case brought under the Hatch-Waxman Act, Sheppard Mullin said.
 
Hanle received a JD from Loyola Law School in 1993 and a BS from the University of California at Los Angeles in 1988. Trusso received a JD from Loyola Law School in 1998 and a BA from San Diego State University in 1995.

The Scan

Breast Cancer Risk Related to Pathogenic BRCA1 Mutation May Be Modified by Repeats

Several variable number tandem repeats appear to impact breast cancer risk and age at diagnosis in almost 350 individuals carrying a risky Ashkenazi Jewish BRCA1 founder mutation.

Study Explores Animated Digital Message Approach to Communicate Genetic Test Results to Family Members

In the Journal of Genetic Counseling, the approach showed promise in participants presented with a hypothetical scenario related to a familial hereditary breast and ovarian cancer syndrome diagnosis.

Computational Tool Predicts Mammalian Messenger RNA Degradation Rates

A tool called Saluki, trained with mouse and human messenger RNA data, appears to improve mRNA half-life predictions by taking RNA and genetic features into account, a Genome Biology paper reports.

UK Pilot Study Suggests Digital Pathway May Expand BRCA Testing in Breast Cancer

A randomized pilot study in the Journal of Medical Genetics points to similar outcomes for breast cancer patients receiving germline BRCA testing through fully digital or partially digital testing pathways.